Sodium Phenylacetate

CHEMBL1200358 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
158.1 g/mol
LogP
Phase
4

Sodium phenylacetate is a nitrogen-scavenging agent used in combination with sodium benzoate for the emergency treatment of acute hyperammonemia in patients with urea cycle disorders. Phenylacetate conjugates with glutamine (via phenylacetylglutamine) in the liver and kidney, enabling renal excretion of excess nitrogen that cannot be eliminated via the defective urea cycle. The combination product (Ammonul) is administered intravenously for acute hyperammonemic crisis.

น้ำหนักโมเลกุล

158.1300 g/mol

TPSA

40.10 Ų

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])Cc1ccccc1.[Na+]

InChI

InChI=1S/C8H8O2.Na/c9-8(10)6-7-4-2-1-3-5-7;/h1-5H,6H2,(H,9,10);/q;+1/p-1

Molecular Formula

C8H7NaO2

HBD / HBA

- / 2

พันธะที่หมุนได้

2

อะตอมหนัก

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Sodium phenylacetate is a nitrogen-scavenging agent used in combination with sodium benzoate for the emergency treatment of acute hyperammonemia in patients with urea cycle disorders. Phenylacetate conjugates with glutamine (via phenylacetylglutamine) in the liver and kidney, enabling renal excretion of excess nitrogen that cannot be eliminated via the defective urea cycle. The combination product (Ammonul) is administered intravenously for acute hyperammonemic crisis.

Yes, Sodium Phenylacetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200358. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23690424. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.